Skip Navigation

Microbiology and Immunology

Emory Receives $28.5 Million NIH Grant for “Innovative HIV/AIDS Vaccine and Cure Research” (06/09/2022)

Emory Researchers Closer to Understanding Mechanisms that Support HIV Persistence (06/09/2022)

A Cure for HIV: Emory Receives $23.8 Million NIH Grant to Accelerate Research (09/07/2021)

New COVID-19 Vaccine Candidate Provides Effective Option for Low- to Mid-Income Countries (07/15/2021)

Yerkes Researchers Develop Low-Cost, Low-Dose RBD Trimer Protein-Based COVID-19 Vaccine Candidate (07/01/2021)

New Combination Immunotherapy Plus ART Expand Innate Cells Critical to Controlling HIV (05/17/2021)

Emory MVA COVID-19 Vaccine Safe and Effective in Animal Models (02/04/2021)

Yerkes Researcher Dr. Amara Featured on Revisionist History Podcast (12/10/2020)

Inflammation-Blocking Medication Effectively Reduces COVID-19 Lung Inflammation (12/10/2020)

Yerkes Researcher Featured on "Your Fantastic Mind" (09/09/2020)

Yerkes Genomics Research Will Help Predict COVID-19 Disease Severity, Inform Treatment Decisions (08/06/2020)

Emory Researchers Show New Adjuvant Successful in Extending Immunity Against HIV (06/19/2020)

Yerkes Researchers Find Zika Infection Soon After Birth Leads to Long-Term Brain and Behavior Problems (05/22/2020)

Yerkes Awarded NIAID Grant to Develop COVID-19 Vaccine (05/18/2020)

New HIV Vaccine Combination Strategy Provides Better and More Durable Protection (05/11/2020)

Immunotherapy Combo Achieves Reservoir Shrinkage in HIV Model (03/17/2020)

In animal models, a 'shocking' step toward a potential HIV cure (01/22/2020)

Creating viral targets can weaken HIV vaccination, Emory scientists warn (11/21/2019)

Researchers Advise Long-Term Monitoring of Infants Infected with Zika Virus Early After Birth (04/04/2018)

Yerkes Researchers Find Clues to AIDS Resistance in Sooty Mangabey Genome (01/03/2018)

Reservoir Explorers Find Extra HIV/SIV Pond (10/17/2017)

Emory Center for AIDS Research Receives $10 Million NIH Renewal (05/08/2017)

Select Antiviral Cells Can Access HIV's Hideouts (01/31/2017)

Scientists Achieve Sustained Remission in SIV Infection (10/13/2016)

Immune-Enhancing Treatment May Destabilize HIV Reservoirs (07/21/2016)

NIH Awards Emory $35.6 Million Grant for Research Aimed at HIV/AIDS Vaccine and Cure (06/07/2016)

IL-21 Repairs Immune Function in Nonhuman Primate Model of HIV Infection (11/09/2015)

Blood-based Biomarkers Could Enable Simple, Accurate TB Tests for Diagnosis and Monitoring (03/30/2015)

Novel Tool Captures Total Body SIV Replication (03/09/2015)

HIV Vaccines Should Avoid Viral Target Cells, Nonhuman Primate Model Study Suggests (01/02/2015)

Yerkes Research Center Receives Phase II Grand Challenges Explorations Funding (12/02/2014)

Masking HIV target cells prevents viral transmission in animal model (11/25/2014)

Immune cells proposed as HIV hideout don't last in primate model (10/31/2014)

Yerkes Researchers First to Show Irradiation Plus Transplantation Effective for Treating HIV/AIDS (09/25/2014)

Intestinal Bacteria Needed for Strong Flu Vaccine Responses in Mice (09/11/2014)

Scientists identify molecular biomarkers of vaccine immunity (12/16/2013)

Vaccine Study Reveals Link Between Immunity, Cells' Starvation Response (12/05/2013)

$19.4_Million_Contract_Establishes_Malaria_Research_Consortium (11/21/2012)

Emory to Receive $6 Million for AIDS Vaccine Research (09/01/2012)

SIV's natural hosts can reveal how humans might better manage HIV Infection (03/08/2012)

Scientists discover effects of PD-1 blockade on antiretroviral therapy in SIV-infected monkeys (03/08/2012)

HIV/AIDS Vaccine Shows Long-Term Protection Against Multiple Exposures in Nonhuman Primates (03/07/2012)

SIV-Resistant Monkeys Close the Gates to Viral Infection (06/27/2011)

Yerkes Researcher Finds Virus-Mimicking Nanoparticles Can Stimulate Long Lasting Immunity (02/23/2011)

Rama Rao Amara, PhD, Featured on Emory Health Now Blog (12/20/2010)

Yerkes Research Sheds Light on Regulatory Cells in the Intestine (08/19/2010)

NIH Awards Emory $15.5 Million to Establish Center for Systems Vaccinology (08/13/2010)

New Insight Into Role Of T-Cells In HIV Infections Increases Understanding Of Immune System (08/05/2010)

Leading HIV Scientist to Join Yerkes as Georgia Research Alliance Eminent Scholar (04/13/2010)

Research Suggests a New Focus for AIDS Vaccine Strategies (02/09/2010)

Yerkes Researchers Propose Ambitious New Strategies For AIDS Vaccine Research (08/07/2009)

Yerkes Plays Vital Role In Unprecedented Study Challenging Prevailing View Of AIDS In Nonhuman Primates (07/30/2009)

Blocking Immune Inhibitor Improves Response to HIV-Like Virus, Prolongs Survival in Monkeys (12/15/2008)

Emory Researchers Discover Strategy For Predicting The Immunity Of Vaccines (11/25/2008)

New Clinical Trial Begins for HIV/AIDS Vaccine Developed at Emory, GeoVax, NIH and CDC (04/15/2006)

Neonatal Porcine Cells Offer Promise for Much-Needed Supply of Islet Cells for Human Diabetic Patients (02/26/2006)

Investigational Transplant Drug Preserves Kidneys While Avoiding Toxic Side Effects Common to Immunosuppressant Medications (02/21/2005)

Emory Researchers Discover Novel Mechanism of How Anthrax Impairs Immunity (07/16/2003)

AIDS Vaccine Developed at Emory University and the National Institutes of Health Moves to Clinical Trials (01/23/2003)

HIV Research Grant

COVID-19 Research